COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs
Abstract
Share and Cite
Lee, J.H.; Kanwar, B.; Khattak, A.; Balentine, J.; Nguyen, N.H.; Kast, R.E.; Lee, C.J.; Bourbeau, J.; Altschuler, E.L.; Sergi, C.M.; et al. COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs. Int. J. Mol. Sci. 2022, 23, 13260. https://doi.org/10.3390/ijms232113260
Lee JH, Kanwar B, Khattak A, Balentine J, Nguyen NH, Kast RE, Lee CJ, Bourbeau J, Altschuler EL, Sergi CM, et al. COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs. International Journal of Molecular Sciences. 2022; 23(21):13260. https://doi.org/10.3390/ijms232113260
Chicago/Turabian StyleLee, Jong Hoon, Badar Kanwar, Asif Khattak, Jenny Balentine, Ngoc Huy Nguyen, Richard E. Kast, Chul Joong Lee, Jean Bourbeau, Eric L. Altschuler, Consolato M. Sergi, and et al. 2022. "COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs" International Journal of Molecular Sciences 23, no. 21: 13260. https://doi.org/10.3390/ijms232113260
APA StyleLee, J. H., Kanwar, B., Khattak, A., Balentine, J., Nguyen, N. H., Kast, R. E., Lee, C. J., Bourbeau, J., Altschuler, E. L., Sergi, C. M., Nguyen, T. N. M., Oh, S., Sohn, M.-G., & Coleman, M. (2022). COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs. International Journal of Molecular Sciences, 23(21), 13260. https://doi.org/10.3390/ijms232113260

